Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.

Scientific reports - 15 Feb 2023

Samy Asmaa, Ozdemir Mehmet Kemal, Alhajj Reda

Abstract excerpt

Splicing factor 3B subunit 1 (SF3B1) is the largest component of SF3b protein complex which is involved in the pre-mRNA splicing mechanism. Somatic mutations of SF3B1 were shown to be associated with aberrant splicing, producing abnormal transcripts that drive cancer development and/or prognosis. In this study, we focus on the relationship between SF3B1 and four types of cancer, namely myelodysplastic syndrome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Leukemia, Lymphocytic, Chronic, B-Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Myelodysplastic Syndromes

Share to Phosphoproteins

Share to Ribonucleoprotein, U2 Small Nuclear

Share to RNA Splicing

Share to RNA Splicing Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 36792691
DOI: 10.1038/s41598-023-29777-5
PMCID: PMC9932172

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.PMID 36792691Read ↗

The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia.Semantic proximity Read ↗

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.Semantic proximity Read ↗

SF3B1 mutations in spliceosome-driven tumorigenesis: From splicing dysregulation to signaling network rewiring and therapeutic targeting.Semantic proximity Read ↗

Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis.Semantic proximity Read ↗

The Role of Splicing Factor SF3B4 in Congenital Diseases and Tumors.Semantic proximity Read ↗

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing.Semantic proximity Read ↗

SF3B1: from core splicing factor to oncogenic driver.Semantic proximity Read ↗

Chemokine Receptor 1 and its associated immune pathway are downregulated in SF3B1 <sup>MT</sup> blood and non-blood cancersSemantic proximity Read ↗

Clinical Characteristics and Molecular Profiling of SF3B1-Mutated Myelodysplastic Syndrome (MDS) in a Real-World Practice.Semantic proximity Read ↗

SF3B1ness score: screening <i>SF3B1</i> mutation status from over 60,000 transcriptomes based on a machine learning approachSemantic proximity Read ↗

Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations.Semantic proximity Read ↗

SF3B1 mutations constitute a novel therapeutic target in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.